Top Markets
Coin of the day
IR Biosciences Holdings Inc. IR Biosciences Holdings Inc.

IR Biosciences Holdings Inc.

IRBS
Clasificación en acciones #40519
IR BioSciences Holdings, Inc. is a U.S.-based, early-stage biotechnology firm.... IR BioSciences Holdings, Inc. is a U.S.-based, early-stage biotechnology firm. Through its subsidiary, ImmuneRegen BioSciences, Inc., it concentrates on researching and developing therapies for significant health challenges, including pulmonary fibrosis, influenza infections, and neutropenia caused by radiation. The company is also actively developing Homspera and its derivatives, Radilex and Viprovex. These compounds are designed to stimulate human stem cells, enhance immune system responses, offer anti-infective properties, serve as vaccine adjuvants, and promote wound healing. Founded in 1999, IR BioSciences Holdings, Inc. maintains its headquarters in Scottsdale, Arizona.
Precio por acción
$0.00006
Última sincronización: 2025-07-15
Capitalización bursátil
$128.12K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio IR Biosciences Holdings Inc. (IRBS)

Categoría

Historial del precio de la acción de IR Biosciences Holdings Inc. (IRBS)
Precio más alto de cierre: $0.00 el 2025-07-01

Precio más bajo de cierre: $0.00 el 2023-06-01
Historial del precio de la acción de IR Biosciences Holdings Inc. desde 2023 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2025 0.00%
2024 5,900.00%
2023 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE